Analysed VALNEVA SE (INRLF:OTCMKTS) News Sources
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
07-09-2026
yahoo.com
Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat
15-09-2026
yahoo.com
Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?
24-09-2026
yahoo.com
VALN Stock Plunges 7% After-Hours As UK Revokes Valneva’s IXCHIQ Authorization In Latest Market Setback
07-10-2026
stocktwits.com
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
14-10-2026
yahoo.com
What is the current price of VALNEVA SE (INRLF:OTCMKTS)?
The current price of VALNEVA SE (INRLF:OTCMKTS) is $2.49.
VALNEVA SE (INRLF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of VALNEVA SE (INRLF:OTCMKTS) since the previous trading day is $-0.88.
VALNEVA SE (INRLF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of VALNEVA SE (INRLF:OTCMKTS) since the previous trading day is -26.1128%.
What is the most recent average sentiment score for VALNEVA SE (INRLF:OTCMKTS)?
The most recent average sentiment score for VALNEVA SE (INRLF:OTCMKTS) is 41 out of 100.
What is the most recent average sentiment for VALNEVA SE (INRLF:OTCMKTS)?
The most recent sentiment for VALNEVA SE (INRLF:OTCMKTS) is .
SEC-8K** Filing Available For VALNEVA SE (INRLF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.